crunch these numbers

ADO is a very wild beast to try and value

A couple of years ago I did some research on the below which gave me a basic understanding of what a portion of the Mixngo technology could be worth.

Ready to follow this tangled web of Biotech companies :

INVITROGEN CORPORATION and APPLIED BIOSYSTEMS merged in 2008 to form LIFE TECHNOLOGIES - Life Tech has just been acquired by THERMO FISHER for $13.6 BILLION

This is the part that I see relevant to ADO :

In 2005 - Life Tech at that stage INVITROGEN acquired Oslo based private company DYNAL BIOTECH (Dynal Beads)

INVITROGEN paid in 2005 for DYNAL : $300m EURO or about $462m in AUD

Why is this relevant?

Have a look at the new products that have been released in particular the beads that are used as an example - LIFE TECHNOLOGIES DYNABEADS M-270 & M-280 Tosyl

The other beads are Merck beads - M1-070/40

There is a massive point here that IMO holders need to understand to understand what value ADO have created.

Firstly :

Merck beads are extremely cheap compared to LIFE TECH Dynal Beads ( I will try and find the prices and update this thread in the next few days)

Pay Attention to the diagram below - ADO has taken an inferior cheaper bead from MERCK and made it perform better than the M-270 and comparable with the M-280
Tosyl.

So - 2 scenarios

Firstly LIFE TECH supply nearly all the Top Ten IVD companies globally - So either Life Tech or now Thermo Fisher would be interested or

Merck beads could be used and made chaper and potentially take market share and profits away from Thermo Fisher/ Life Tech


To summarise in 2005 - Life Tech paid $460m to get hold of DYNAL BIOTECH to capture their market leading bead technology.

This has worked well for them

BUT

Enter MIXNGO

This makes this product seem inferior

Add what value you like to this scenario - But IMO It has given me a very solid belief in the value of the technology over the past couple of years.

Success will come for ADO - As a holder know the potential and dont sell yourself short without researching.

This is just the value Life Tech paid for the bead technology for DYNAL beads

This is but only 1 use for Anteos MIXNGO and this alone would see a valuation of in excess of $500m if you understand where I am coming from - On a better bead technology alone this would value ANTEO at 60 cents per share - And this isnt even considering the value of the POINT OF CARE market / Bioseparations

Yes it takes some lateral thinking to assess this opportunity but I am more than happy with my calculations

Any way I could go on - In short - This is bigger than most of you think and my reading of others posts here confirms that (No disrespect meant by that comment)